| 000 | 01780 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516023424.0 | ||
| 264 | 0 | _c20110325 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature09855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYazawa, Masayuki | |
| 245 | 0 | 0 |
_aUsing induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. _h[electronic resource] |
| 260 |
_bNature _cMar 2011 |
||
| 300 |
_a230-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 | _aAutistic Disorder |
| 650 | 0 | 4 |
_aCalcium Channels, L-Type _xgenetics |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 | _aCell Transdifferentiation |
| 650 | 0 | 4 |
_aCellular Reprogramming _xgenetics |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xpathology |
| 650 | 0 | 4 |
_aLong QT Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aMutation, Missense _xgenetics |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 | _aRoscovitine |
| 650 | 0 | 4 | _aSingle-Cell Analysis |
| 650 | 0 | 4 |
_aSyndactyly _xdrug therapy |
| 700 | 1 | _aHsueh, Brian | |
| 700 | 1 | _aJia, Xiaolin | |
| 700 | 1 | _aPasca, Anca M | |
| 700 | 1 | _aBernstein, Jonathan A | |
| 700 | 1 | _aHallmayer, Joachim | |
| 700 | 1 | _aDolmetsch, Ricardo E | |
| 773 | 0 |
_tNature _gvol. 471 _gno. 7337 _gp. 230-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature09855 _zAvailable from publisher's website |
| 999 |
_c20585628 _d20585628 |
||